BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37058762)

  • 41. Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma.
    Fan Z; Wu S; Sang H; Li Q; Cheng S; Zhu H
    Mediators Inflamm; 2023; 2023():9162249. PubMed ID: 37035759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STK11 mutation affects the killing effect of NK cells to promote the progression of lung adenocarcinoma.
    Huang Y; Zhang H; Feng J; Tang B
    APMIS; 2022 Nov; 130(11):647-656. PubMed ID: 35988018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma.
    Fang L; Yu W; Zhu P; Yu G; Ye B
    Sci Rep; 2023 Mar; 13(1):5006. PubMed ID: 36973475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a novel snoRNA expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on RNA sequencing dataset.
    Zhang L; Xin M; Wang P
    Math Biosci Eng; 2021 Sep; 18(6):7837-7860. PubMed ID: 34814278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis.
    Zhang Z; Qi D; Liu X; Kang P
    Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
    Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
    Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
    Uddin MN; Akter R; Li M; Abdelrahman Z
    Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences.
    Fan T; Li C; He J
    Biol Sex Differ; 2021 Dec; 12(1):64. PubMed ID: 34863300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis.
    Qin FL; Xu ZY; Yuan LQ; Chen WJ; Wei JB; Sun Y; Li SK
    FEBS Open Bio; 2020 Sep; 10(9):1921-1933. PubMed ID: 32686362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.
    Chen C; Tang Y; Qu WD; Han X; Zuo JB; Cai QY; Xu G; Song YX; Ke XX
    BMC Cancer; 2021 May; 21(1):619. PubMed ID: 34039308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Aizemaiti R; Wu Z; Tang J; Yan H; Lv X
    Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma.
    He M; Han Y; Cai C; Liu P; Chen Y; Shen H; Xu X; Zeng S
    J Cell Mol Med; 2021 Apr; 25(7):3391-3399. PubMed ID: 33655701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma.
    Huang H; Yu H; Li X; Li Y; Zhu G; Su L; Li M; Chen C; Gao M; Wu D; Zhang R; Cao P; Liu H; Chen J
    Front Immunol; 2022; 13():993890. PubMed ID: 36505472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway.
    Luan T; Zhang TY; Lv ZH; Guan BX; Xu JY; Li J; Li MX; Hu SL
    FEBS Open Bio; 2021 May; 11(5):1504-1515. PubMed ID: 33683834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Novel Role of Arrhythmia-Related Gene
    Chang KT; Wu HJ; Liu CW; Li CY; Lin HY
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
    He J; Lan X; Liu X; Deng C; Luo H; Wang Y; Kang P; Sun Z; Zhao L; Zhou X
    BMC Cancer; 2023 Mar; 23(1):266. PubMed ID: 36959566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.